1. Guidance for Industry: Uncomplicated and complicated skin and skin structure infections: developing antimicrobial drugs treatment. US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, 1998. Available at: http://www.fda.gov/CDER/guidance/2566dft.pdf. Accessed October 17, 2008.
2. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy;Jones;Int J Antimicrob Agents,2003
3. Practice guidelines for the diagnosis and management of skin and soft-tissue infections;Stevens;Clin Infect Dis,2005
4. Necrotizing soft tissue infections: risk factors for mortality and strategies for management;Elliott;Ann Surg,1996
5. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY antimicrobial surveillance program (1998–2004);Moet;Diagn Microbiol Infect Dis,2007